Cargando…
Rapid emergence from dexmedetomidine sedation in Sprague Dawley rats by repurposing an α(2)-adrenergic receptor competitive antagonist in combination with caffeine
BACKGROUND: The α(2) adrenergic receptor agonist dexmedetomidine is an important intravenous sedative with analgesic properties. Currently available dexmedetomidine reversal agents, like the α(2)-receptor antagonist atipamezole, cause serious adverse effects at the large dosages required for effecti...
Autores principales: | Xie, Zheng, Fox, Aaron P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890710/ https://www.ncbi.nlm.nih.gov/pubmed/36721095 http://dx.doi.org/10.1186/s12871-023-01986-5 |
Ejemplares similares
-
Sedation improves early outcome in severely septic Sprague Dawley rats
por: Qiao, Hong, et al.
Publicado: (2009) -
Solitary foot mass on a Sprague-Dawley rat
por: Rosenbaum, Matthew D, et al.
Publicado: (2010) -
Ovarian neoplasia in the Sprague-Dawley rat.
por: Lewis, D J
Publicado: (1987) -
Hematoxicity of Amodiaquine in Sprague-Dawley Rats
por: Saka, W. A., et al.
Publicado: (2012) -
Keishibukuryogan is not carcinogenic in Sprague-Dawley rats
por: Kanitani, Masanao, et al.
Publicado: (2016)